Gregory Fulcher

Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes

Satish K. Garg, Robert R. Henry, Phillip Banks et al. · New England Journal of Medicine · 2017 · 416 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds

Sophia Zoungas, John Chalmers, Toshiharu Ninomiya et al. · Diabetologia · 2011 · 358 citations · Full text

Medicine, Endocrinology, Internal Medicine +15

Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial

John R. Petrie, Nish Chaturvedi, Ian Ford et al. · The Lancet Diabetes & Endocrinology · 2017 · 347 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +14

Unrecognized Hypo- and Hyperglycemia in Well-Controlled Patients with Type 2 Diabetes Mellitus: The Results of Continuous Glucose Monitoring

L.C. Hay, E. G. Wilmshurst, Gregory Fulcher · Diabetes Technology & Therapeutics · 2003 · 144 citations

Medicine, Endocrinology, Geriatric Medicine +17

Comparison of Insulin Degludec/Insulin Aspart and Biphasic Insulin Aspart 30 in Uncontrolled, Insulin-Treated Type 2 Diabetes: A Phase 3a, Randomized, Treat-to-Target Trial

Gregory Fulcher, Jens Sandahl Christiansen, Ganapathi Bantwal et al. · Diabetes Care · 2014 · 111 citations

Medicine, Endocrinology, Pharmacotherapy +17